A new article published in RadioGraphics examines the use of monoclonal antibody therapies for treating Alzheimer’s disease and alerts physicians to be on the lookout for a potential side effect: amyloid-related imaging abnormalities (ARIA).
A new article published in RadioGraphics examines the use of monoclonal antibody therapies for treating Alzheimer’s disease and alerts physicians to be on the lookout for a potential side effect: amyloid-related imaging abnormalities (ARIA).